ECSP034501A - TABLETS CONTAINING EPINASTINE MANUFACTURED BY DIRECT COMPRESSION - Google Patents

TABLETS CONTAINING EPINASTINE MANUFACTURED BY DIRECT COMPRESSION

Info

Publication number
ECSP034501A
ECSP034501A EC2003004501A ECSP034501A ECSP034501A EC SP034501 A ECSP034501 A EC SP034501A EC 2003004501 A EC2003004501 A EC 2003004501A EC SP034501 A ECSP034501 A EC SP034501A EC SP034501 A ECSP034501 A EC SP034501A
Authority
EC
Ecuador
Prior art keywords
manufactured
direct compression
tablets containing
containing epinastine
epinastine
Prior art date
Application number
EC2003004501A
Other languages
Spanish (es)
Inventor
Toshimitsu Ohki
Kazutoshi Yokoyama
Wakuko Yamaguchi
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ECSP034501A publication Critical patent/ECSP034501A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere a un comprimido fabricado por un procedimiento de compresión directa, que comprende Epinastina como un agente activo, con una estabilidad en el almacenamiento mejorada.The present invention relates to a tablet manufactured by a direct compression method, comprising Epinastine as an active agent, with improved storage stability.

EC2003004501A 2000-09-08 2003-03-05 TABLETS CONTAINING EPINASTINE MANUFACTURED BY DIRECT COMPRESSION ECSP034501A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000315849A JP2002087963A (en) 2000-09-08 2000-09-08 Epinastine-containing tablets manufactured by direct compression

Publications (1)

Publication Number Publication Date
ECSP034501A true ECSP034501A (en) 2003-04-25

Family

ID=18794888

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004501A ECSP034501A (en) 2000-09-08 2003-03-05 TABLETS CONTAINING EPINASTINE MANUFACTURED BY DIRECT COMPRESSION

Country Status (6)

Country Link
JP (1) JP2002087963A (en)
AU (1) AU2001291820A1 (en)
BR (1) BR0113731A (en)
EC (1) ECSP034501A (en)
MX (1) MXPA03002013A (en)
WO (1) WO2002020018A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014353A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
JP5162141B2 (en) * 2007-02-20 2013-03-13 エスエス製薬株式会社 Film coating composition
JP5291324B2 (en) * 2007-11-01 2013-09-18 沢井製薬株式会社 Orally disintegrating tablets
JP5806490B2 (en) * 2011-03-31 2015-11-10 エスエス製薬株式会社 Film coating composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19542281C2 (en) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Use of Epinastin for the treatment of migraines
DK1041990T3 (en) * 1997-12-23 2006-10-02 Schering Corp Composition for the treatment of respiratory and skin diseases with at least one leukotriene antagonist and at least one antihistamine
EP1000623A1 (en) * 1998-09-29 2000-05-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Use of epinastine as antitussivum
JP4016128B2 (en) * 1999-09-09 2007-12-05 東和薬品株式会社 Light-resistant epinastine hydrochloride film-coated tablets

Also Published As

Publication number Publication date
AU2001291820A1 (en) 2002-03-22
MXPA03002013A (en) 2003-07-24
BR0113731A (en) 2003-07-29
JP2002087963A (en) 2002-03-27
WO2002020018A1 (en) 2002-03-14
WO2002020018A8 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
CL2008002407A1 (en) Oral dosage form comprising at least one nicotine active agent, at least one bioadhesive material capable of forming a hydrogen bond with the nicotine active agent, and at least one rapidly releasing sensory impact agent; and its use to provide rapid relief from nicotine cravings (div. sol. 1825-04).
HN2008000792A (en) BICYCLE CINAMIDE COMPOSITE
DE60334678D1 (en) ANTIBODY-CONTAINING PHARMACEUTICAL SOLUTIONS
MXPA05012201A (en) CONJUGATES OF ACTIVE PROTEIN POLYMER AGENTS OF REPETITION SEQUENCE, METHODS AND USES.
MX2007015424A (en) Topical ungual formulations.
AR049083A1 (en) PROCESS FOR THE PREPARATION OF A SOLID PROOF OF DOSAGE FORM OF ABUSE
SV1999000068A (en) STABILIZED ANTIHISTAMINIC SYRUP
ES2096103T3 (en) PREPARATION OF INCREASED RESISTANCE TABLETS.
AR077864A1 (en) FLOATING MICROGRANULES
ECSP034868A (en) INHALATION CAPSULES
MX2011009131A (en) THICK ADDITIVE COMPOSITIONS.
UY27886A1 (en) PHARMACEUTICAL COMPOSITION THAT HAS A DISTRIBUTION AND UNIFORM POWER OF FARMACO.
ZA200408378B (en) Clear antiperspirant with alcohol free active.
BR0212227B1 (en) Fruit thinning agent and processes as well as their employment
UY31452A1 (en) IMPROVED TABLET COATING
ECSP034501A (en) TABLETS CONTAINING EPINASTINE MANUFACTURED BY DIRECT COMPRESSION
CO5540370A2 (en) COMPRESSED UNDERSTANDING CETIRIZINE AND PSEUDOEFREDINA
ES2421379T3 (en) Therapeutic composition based on clay
AR033596A1 (en) PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR INJECTION CONTAINING LOXOPROPHENE
PL376130A1 (en) Controlled releases system containing temozolomide
MXPA05004656A (en) Acetals as insect repellant agents.
AR059107A1 (en) ESTER COMPOUND AND ITS USE
FR2856765B1 (en) ACTIVE DYNAMIC BATTERY
AR048672A1 (en) DISINTEGRATION TABLETS THAT INCLUDE LICARBAZEPINA
ES2140673T3 (en) HELICOBACTER PYLORI CATALASE BASED IMMUNIZING COMPOSITION.